$1.31

-0.29 (-18.13%)
Live
Previous Close

$1.31

Day Range

$1.25 - $1.43

Previous Day Range

$1.6 - $1.7

Market Cap

$ USD

Day Vol.

8245

Previous Day Vol.

206

Currency

USD

Primary Exchange

Nasdaq

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Alvotech will release its first half 2025 financial results via webcast on August 14, 2025, at 12:00 PM, accessible through their investor website. The company is a biotech firm focused on developing biosimilar medicines globally.

Related tickers: ALVO, ALVOW, TEVA.

Read Full Article

Alvotech, a global biopharmaceutical company specializing in biosimilar medicines, will host a webcast on August 14, 2025, to present its financial results for the first half of the year. The company has developed two biosimilars and has a portfolio of nine biosimilar candidates targeting various medical conditions.

Related tickers: ALVO, ALVOW, TEVA.

Read Full Article
Trending Tickers

Please sign in to view